Professor in Hematology/Oncology & Bone Marrow Transplant in the Department of Pediatrics, Denver School of Medicine, University of Colorado, USA
United States
Prof. Michael Verneris, MD, is a distinguished professor of Pediatrics specializing in hematology, oncology, and bone marrow transplantation. With over 25 years of experience, he has held esteemed positions at institutions in the United States such as Stanford University, the University of Minnesota, and the University of Colorado. He has contributed to groundbreaking research on immune system modulation and cancer therapy. As Director of Bone Marrow Transplant and Stem Cell Therapy at Children’s Hospital Colorado, Prof. Verneris provides cutting-edge care for complex hematologic conditions.
Prof. Michael Verneris, MD, is a highly accomplished pediatric hematologist, oncologist, and stem cell transplant specialist with over 25 years of clinical and research expertise. A graduate of Brown University’s Warren Alpert School of Medicine, USA, Prof. Verneris completed his pediatric residency at Children’s National Medical Center, followed by a fellowship in hematology/oncology and bone marrow transplantation at Stanford University, USA. His career is marked by leadership roles at top institutions, including the University of Minnesota and the University of Colorado, where he currently serves as Director of Bone Marrow Transplant and Stem Cell Therapy at Children’s Hospital Colorado.
Prof. Verneris is renowned for his expertise in treating pediatric leukemia and other hematologic malignancies, focusing on advanced cellular therapies such as CAR-T, NK-cell therapy, and stem cell transplantation. His clinical work addresses complex cases involving relapse, refractory disease, and graft-versus-host disease, utilizing innovative approaches to enhance patient outcomes. A strong proponent of evidence-based medicine, he has also contributed significantly to the development of immunotherapeutic strategies targeting cancer at its cellular level.
In addition to his clinical achievements, Prof. Verneris is an accomplished researcher and educator. He has authored numerous peer-reviewed publications and book chapters. He has been a principal investigator on several high-impact clinical trials and NIH-funded studies, advancing the fields of cellular therapy and transplantation. His work has garnered prestigious accolades, including the Laura Barton Endowed Chair in Pediatric Bone Marrow Transplant and recognition in “Best Doctors in America.”
Prof. Verneris actively engages in mentorship, shaping the next generation of leaders in pediatric oncology and transplantation. He has served on multiple advisory boards and committees, including the American Society of Hematology and the American Society for Transplantation and Cellular Therapy. Through his leadership, research, and clinical care, Prof. Verneris continues to transform the landscape of pediatric cancer treatment, offering hope to families facing life-threatening conditions.
Cancer Center, Anschutz Medical Campus, University of Colorado, USA
Anschutz Medical Campus, University of Colorado, USA
Cancer Center, Anschutz Medical Campus, University of Colorado, USA
Children’s Hospital Colorado, School of Medicine, University of Colorado, USA
Department of Pediatrics, Denver School of Medicine, University of Colorado, USA
Department of Pediatrics, University of Minnesota, USA
Division of Blood and Marrow Transplantation, Twin Cities Campus, Department of Pediatrics, Medical School, University of Minnesota, USA
Institutional Reviewer Board (IRB), National Marrow Donor Program (NMDP)
OptumHealth Care Solutions, Clinical Sciences Institute, Bone Marrow Transplant Expert Panel
University of Minnesota Medical Center, Fairview, Minneapolis, Minnesota, USA
Division of Bone Marrow Transplantation, Department of Pediatrics, University of California at San Francisco, San Francisco, USA California
1998
1995
Chair, CIBMTR (Center for International Blood & Marrow Transplant Research) Advisory Committee (2020)
Cellular Therapy Committee (2016)
Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Pediatric Transplantation & Cellular Therapy (2007)
American Society for Blood and Marrow Transplantation (2006)
American Society of Hematology (1997)